The paradox of immunosuppressants and COVID-19

Lessons learned from a large registry analysis show worse COVID-19 outcomes for patients previously exposed to glucocorticoids https://bit.ly/306rNrk

Detalles Bibliográficos
Autores principales: Cheng, Guang-Shing, Evans, Scott E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607867/
https://www.ncbi.nlm.nih.gov/pubmed/34795039
http://dx.doi.org/10.1183/13993003.02828-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607867/
https://www.ncbi.nlm.nih.gov/pubmed/34795039
http://dx.doi.org/10.1183/13993003.02828-2021

Ejemplares similares